Search research articles
Contact Us
Filters
Showing results (11-20 of 141) with videos related to
Page
of 15
Sort By:
Brain and Behavior
|
June 10, 2022
Real-world evidence following a mandatory treatment break after a 1-year prophylactic treatment with calcitonin gene-related peptide (pathway) monoclonal antibodies
Michael Nsaka, Armin Scheffler, Sebastian Wurthmann, et al.
Neuro-Oncology Advances
|
June 16, 2022
Brain tumor patients and COVID-19 vaccines: results of an international survey
Mathew R Voisin, Kathy Oliver, Stuart Farrimond, et al.
Oncology
|
January 17, 2008
Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series
Martin Glas, Horst Koch, Birgit Hirschmann, et al.
The Journal of Headache and Pain
|
July 5, 2020
Erenumab in highly therapy-refractory migraine patients: First German real-world evidence
Armin Scheffler, Olga Messel, Sebastian Wurthmann, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 16, 2007
Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma
Martin Glas, Burkhard Hennemann, Birgit Hirschmann, et al.
Molecular Neurobiology
|
February 6, 2019
Blood-Based Biomarkers in High Grade Gliomas: a Systematic Review
Daniela Pierscianek, Yahya Ahmadipour, Marvin Darkwah Oppong, et al.
Environmental Pollution (Barking, Essex : 1987)
|
March 8, 2014
The Danube so colourful: a potpourri of plastic litter outnumbers fish larvae in Europe's second largest river
Aaron Lechner, Hubert Keckeis, Franz Lumesberger-Loisl, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 9, 2011
Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine
Niklas Schaefer, Katja Rasch, Markus Moehlenbruch, et al.
Neuro-Oncology Advances
|
October 9, 2023
Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022
Christoph Oster, Teresa Schmidt, Sarina Agkatsev, et al.
Oncology
|
June 20, 2014
Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma
Frederic Mack, Niklas Schäfer, Sied Kebir, et al.
Page
of 15
Search research articles
Search
Showing results (11-20 of 141) with videos related to
Sort By:
Page
of 15
Brain and Behavior
|
June 10, 2022
Real-world evidence following a mandatory treatment break after a 1-year prophylactic treatment with calcitonin gene-related peptide (pathway) monoclonal antibodies
Michael Nsaka, Armin Scheffler, Sebastian Wurthmann, et al.
Neuro-Oncology Advances
|
June 16, 2022
Brain tumor patients and COVID-19 vaccines: results of an international survey
Mathew R Voisin, Kathy Oliver, Stuart Farrimond, et al.
Oncology
|
January 17, 2008
Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series
Martin Glas, Horst Koch, Birgit Hirschmann, et al.
The Journal of Headache and Pain
|
July 5, 2020
Erenumab in highly therapy-refractory migraine patients: First German real-world evidence
Armin Scheffler, Olga Messel, Sebastian Wurthmann, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 16, 2007
Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma
Martin Glas, Burkhard Hennemann, Birgit Hirschmann, et al.
Molecular Neurobiology
|
February 6, 2019
Blood-Based Biomarkers in High Grade Gliomas: a Systematic Review
Daniela Pierscianek, Yahya Ahmadipour, Marvin Darkwah Oppong, et al.
Environmental Pollution (Barking, Essex : 1987)
|
March 8, 2014
The Danube so colourful: a potpourri of plastic litter outnumbers fish larvae in Europe's second largest river
Aaron Lechner, Hubert Keckeis, Franz Lumesberger-Loisl, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 9, 2011
Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine
Niklas Schaefer, Katja Rasch, Markus Moehlenbruch, et al.
Neuro-Oncology Advances
|
October 9, 2023
Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022
Christoph Oster, Teresa Schmidt, Sarina Agkatsev, et al.
Oncology
|
June 20, 2014
Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma
Frederic Mack, Niklas Schäfer, Sied Kebir, et al.
Page
of 15